Comments
Dr Reddy’s Laboratories Ltd has received approval from the US Food and Drug Administration (USFDA) for Aspirin and extended-release Dipyridamole capsules.
This is a therapeutic equivalent generic version of Aggrenox (Aspirin and extended-release Dipyridamole) capsules. Aggrenox is a registered trademark of Boehringer Ingelheim. The company is working towards launching the product in the US market.
Aggrenox brand and generic had US sales of approximately $183 million for the most recent 12 months ended August 2018, according to IMS Health. According to a company release, Aspirin and extended-release Dipyridamole capsules are available in 25 mg/200 mg strength with 60 count bottle size.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.